POS1506 IDENTIFYING DETERMINANTS OF FAVOURABLE AND POOR PHYSICAL FUNCTION IN SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS FROM AN INTERNATIONAL COLLABORATIVE STUDY Article Swipe
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1136/annrheumdis-2023-eular.3754
Background Systemic lupus erythematosus (SLE) can result in impaired daily physical function through various mechanisms including active disease, chronic damage, and mental health symptoms that are common in the disease. However, the key drivers of reduced physical function are poorly understood, and no large-scale global studies investigating this have been conducted to date. Objectives To investigate key factors that contribute to impaired physical function in SLE globally. Methods SLE patients were identified from the COVAD 2 database, a global register of more than 20,000 respondents. Healthy controls (HC) were included to compare differences in physical function using the Patient Reported Outcome Measurement Information System (PROMIS) questionnaire. Demographics, medication, comorbidities, disease activity, Global Physical Health (GPH) and Global Mental Health (GMH) were collected. Multivariable regression analysis was used to identify contributing factors to favourable or poor physical function (measured by PROMIS Physical Function shortform PF-10a score). Results 979 SLE patients and 3358 HCs were included in analysis. Patients with SLE had significantly lower PF-10a score as compared to HCs (median 42, IQR 36-47 vs median 49, IQR 45-50, p<0.0001). Determinants of physical function status in patients with SLE are summarised in Table 1. Briefly, factors associated with poor physical function included increasing age (-0.042, 95% CI -0.069 to -0.015, p=0.002) and methotrexate use (-0.928, 95% CI -1.844 to -0.012, p=0.047). Diabetes (-1.862, 95% CI -3.481 to -0.243, p=0.024) and interstitial lung disease (ILD) (-2.441, 95% CI -4.366 to -0.517, p=0.013), but not asthma or COPD, also contributed to lower PF-10a score. From a mental health perspective, anxiety (-0.970, 95% CI -1.853 to -0.087, p=0.031) but not depression contributed to a lower physical function score. Higher Pain Visual Analogue Scales (VAS) (-2.889, 95% CI -3.107 to -2.671, p<0.001) and Fatigue VAS (-1.459, 95% CI -1.974 to -0.945, p<0.001) also contributed to lower PF-10 scores. Hydroxychloroquine use (0.844, 95% CI 0.190 to 1.498, p=0.012) and higher GPH score (2.287, 95% CI 2.079 to 2.494, p<0.001) were associated with favourable physical function. Conclusion Patients with SLE show significantly reduced physical function compared with HCs. Key contributors to poor physical function include intercurrent diabetes and ILD. Screening for, and aggressive early treatment of these conditions may confer improved long-term function. As expected, higher levels of pain and fatigue were associated with poor physical function. Methotrexate use was also identified as a contributing factor to reduced function, which could represent its use in articular manifestations that limit physical function. Importantly, use of hydroxychloroquine was associated with favourable physical function, adding to the well-recognised benefits of this drug in SLE. REFERENCES: NIL. Acknowledgements: NIL. Disclosure of Interests Sook Yan Lee: None declared, Amelia Holloway: None declared, Elena Nikiphorou Speakers bureau: Has received speaker honoraria/participated in advisory boards for Celltrion, Pfizer, Sanofi, Gilead, Galapagos, AbbVie, and Lilly, Consultant of: Has received speaker honoraria/participated in advisory boards for Celltrion, Pfizer, Sanofi, Gilead, Galapagos, AbbVie, and Lilly, Grant/research support from: Holds research grants from Pfizer and Lilly, Ioannis Parodis Grant/research support from: Has received research funding and/or honoraria from Amgen, AstraZeneca, Aurinia Pharmaceuticals, Elli Lilly and Company, Gilead Sciences, GlaxoSmithKline, Janssen Pharmaceuticals, Novartis and F. Hoffmann-La Roche AG., Naveen Ravichandran: None declared, Jessica Day Grant/research support from: Has received research funding from CSL Limited., Mrudula Joshi: None declared, Sreoshy Saha: None declared, Kshitij Jagtap: None declared, Wanruchada Katchamart: None declared, Phonpen Akarawatcharangura Goo: None declared, Binit Vaidya: None declared, Tsvetelina Velikova Speakers bureau: Has received speaker honoraria from Pfizer and AstraZeneca., Parikshit Sen: None declared, Samuel Katsuyuki Shinjo: None declared, Vishwesh Agarwal: None declared, Ai Lyn Tan Speakers bureau: Has received honoraria for advisory boards and speaking for Abbvie, Gilead, Janssen, Lilly, Novartis, Pfizer, and UCB., Consultant of: Has received honoraria for advisory boards and speaking for Abbvie, Gilead, Janssen, Lilly, Novartis, Pfizer, and UCB., Nelly Ziade Speakers bureau: Has received speaker fees, advisory board fees, and research grants from Pfizer, Roche, Abbvie, Eli Lilly, NewBridge, Sanofi-Aventis, Boehringer Ingelheim, Janssen, and Pierre Fabre; none are related to this manuscript., Consultant of: Has received speaker fees, advisory board fees, and research grants from Pfizer, Roche, Abbvie, Eli Lilly, NewBridge, Sanofi-Aventis, Boehringer Ingelheim, Janssen, and Pierre Fabre; none are related to this manuscript., Grant/research support from: Has received speaker fees, advisory board fees, and research grants from Pfizer, Roche, Abbvie, Eli Lilly, NewBridge, Sanofi-Aventis, Boehringer Ingelheim, Janssen, and Pierre Fabre; none are related to this manuscript., Marcin Milchert: None declared, Abraham Edgar Gracia-Ramos: None declared, Carlo Vinicio Caballero: None declared, Hector Chinoy Speakers bureau: Has received speaking fees from UCB and Biogen, Consultant of: Has received consulting fees from Novartis, Eli Lilly, Orphazyme, Astra Zeneca, Grant/research support from: Has received grant support from Eli Lilly and UCB. Was also supported by the National Institution for Health Research Manchester Biomedical Research Centre Funding Scheme. The views expressed in this publication are those of the authors and not necessarily those of the NHS, National Institute for Health Research, or Department of Health., Vikas Agarwal: None declared, Rohit Aggarwal Consultant of: Consultant of: Mallinckrodt, Octapharma, CSL Behring, Bristol. Myers-Squibb, EMD Serono, Q32, Kezar, Pfizer, AstraZeneca, Alexion, Argenx, Boehringer Ingelheim (BI), Corbus, Janssen, Kyverna, Roivant, Merck, Galapagos, Actigraph, Scipher, Horizon Therapeutics, Teva, Beigene, ANI Pharmaceuticals, Biogen, Nuvig, Capella Bioscience, CabalettaBio., Grant/research support from: Grant/research support from: Mallinckrodt, Pfizer, Bristol Myers-Squibb, Q32, EMD Serono, Janssen, Boehringer Ingelheim (BI), Latika Gupta: None declared, Chris Wincup: None declared.
Related Topics
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1136/annrheumdis-2023-eular.3754
- https://ard.bmj.com/content/annrheumdis/82/Suppl_1/1110.2.full.pdf
- OA Status
- gold
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4379798584
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4379798584Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1136/annrheumdis-2023-eular.3754Digital Object Identifier
- Title
-
POS1506 IDENTIFYING DETERMINANTS OF FAVOURABLE AND POOR PHYSICAL FUNCTION IN SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS FROM AN INTERNATIONAL COLLABORATIVE STUDYWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2023Year of publication
- Publication date
-
2023-05-30Full publication date if available
- Authors
-
S. Y. Lee, Amelia Holloway, Elena Nikiphorou, Ioannis Parodis, N. Ravichandran, Jessica Day, Mohit Joshi, Sreoshy Saha, Kshitij Jagtap, Wanruchada Katchamart, Phonpen Akawatcharangura Goo, Bijay Vaidya, Tsvetelina Velikova, Parikshit Sen, Samuel Katsuyuki Shinjo, Vikas Agarwal, Ai Lyn Tan, Nelly Ziadé, Marcin Milchert, A. E. Gracia-Ramos, C. Vinicio Caballero, Hector Chinoy, Vikas Agarwal, Rohit Aggarwal, Latika Gupta, Chris WincupList of authors in order
- Landing page
-
https://doi.org/10.1136/annrheumdis-2023-eular.3754Publisher landing page
- PDF URL
-
https://ard.bmj.com/content/annrheumdis/82/Suppl_1/1110.2.full.pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://ard.bmj.com/content/annrheumdis/82/Suppl_1/1110.2.full.pdfDirect OA link when available
- Concepts
-
Medicine, Internal medicine, Quality of life (healthcare), Disease, Physical therapy, NursingTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4379798584 |
|---|---|
| doi | https://doi.org/10.1136/annrheumdis-2023-eular.3754 |
| ids.doi | https://doi.org/10.1136/annrheumdis-2023-eular.3754 |
| ids.openalex | https://openalex.org/W4379798584 |
| fwci | 0.0 |
| type | article |
| title | POS1506 IDENTIFYING DETERMINANTS OF FAVOURABLE AND POOR PHYSICAL FUNCTION IN SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS FROM AN INTERNATIONAL COLLABORATIVE STUDY |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | 1112 |
| biblio.first_page | 1110.2 |
| topics[0].id | https://openalex.org/T10308 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9769999980926514 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2745 |
| topics[0].subfield.display_name | Rheumatology |
| topics[0].display_name | Systemic Lupus Erythematosus Research |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C71924100 |
| concepts[0].level | 0 |
| concepts[0].score | 0.9052407145500183 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[0].display_name | Medicine |
| concepts[1].id | https://openalex.org/C126322002 |
| concepts[1].level | 1 |
| concepts[1].score | 0.5496562123298645 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[1].display_name | Internal medicine |
| concepts[2].id | https://openalex.org/C2779951463 |
| concepts[2].level | 2 |
| concepts[2].score | 0.4550503194332123 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q7268788 |
| concepts[2].display_name | Quality of life (healthcare) |
| concepts[3].id | https://openalex.org/C2779134260 |
| concepts[3].level | 2 |
| concepts[3].score | 0.42496025562286377 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q12136 |
| concepts[3].display_name | Disease |
| concepts[4].id | https://openalex.org/C1862650 |
| concepts[4].level | 1 |
| concepts[4].score | 0.36921602487564087 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q186005 |
| concepts[4].display_name | Physical therapy |
| concepts[5].id | https://openalex.org/C159110408 |
| concepts[5].level | 1 |
| concepts[5].score | 0.0 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q121176 |
| concepts[5].display_name | Nursing |
| keywords[0].id | https://openalex.org/keywords/medicine |
| keywords[0].score | 0.9052407145500183 |
| keywords[0].display_name | Medicine |
| keywords[1].id | https://openalex.org/keywords/internal-medicine |
| keywords[1].score | 0.5496562123298645 |
| keywords[1].display_name | Internal medicine |
| keywords[2].id | https://openalex.org/keywords/quality-of-life |
| keywords[2].score | 0.4550503194332123 |
| keywords[2].display_name | Quality of life (healthcare) |
| keywords[3].id | https://openalex.org/keywords/disease |
| keywords[3].score | 0.42496025562286377 |
| keywords[3].display_name | Disease |
| keywords[4].id | https://openalex.org/keywords/physical-therapy |
| keywords[4].score | 0.36921602487564087 |
| keywords[4].display_name | Physical therapy |
| language | en |
| locations[0].id | doi:10.1136/annrheumdis-2023-eular.3754 |
| locations[0].is_oa | True |
| locations[0].source | |
| locations[0].license | |
| locations[0].pdf_url | https://ard.bmj.com/content/annrheumdis/82/Suppl_1/1110.2.full.pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | proceedings-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Scientific Abstracts |
| locations[0].landing_page_url | https://doi.org/10.1136/annrheumdis-2023-eular.3754 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5015353587 |
| authorships[0].author.orcid | |
| authorships[0].author.display_name | S. Y. Lee |
| authorships[0].countries | GB |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4210153400 |
| authorships[0].affiliations[0].raw_affiliation_string | King's College Hospital, Rheumatology Department, London, United Kingdom |
| authorships[0].institutions[0].id | https://openalex.org/I4210153400 |
| authorships[0].institutions[0].ror | https://ror.org/044nptt90 |
| authorships[0].institutions[0].type | healthcare |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210111135, https://openalex.org/I4210153400 |
| authorships[0].institutions[0].country_code | GB |
| authorships[0].institutions[0].display_name | King's College Hospital |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | S. Y. Lee |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | King's College Hospital, Rheumatology Department, London, United Kingdom |
| authorships[1].author.id | https://openalex.org/A5072749229 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-3184-931X |
| authorships[1].author.display_name | Amelia Holloway |
| authorships[1].countries | GB |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I4210153400 |
| authorships[1].affiliations[0].raw_affiliation_string | King's College Hospital, Rheumatology Department, London, United Kingdom |
| authorships[1].institutions[0].id | https://openalex.org/I4210153400 |
| authorships[1].institutions[0].ror | https://ror.org/044nptt90 |
| authorships[1].institutions[0].type | healthcare |
| authorships[1].institutions[0].lineage | https://openalex.org/I4210111135, https://openalex.org/I4210153400 |
| authorships[1].institutions[0].country_code | GB |
| authorships[1].institutions[0].display_name | King's College Hospital |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | A. Holloway |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | King's College Hospital, Rheumatology Department, London, United Kingdom |
| authorships[2].author.id | https://openalex.org/A5009133635 |
| authorships[2].author.orcid | https://orcid.org/0000-0001-6847-3726 |
| authorships[2].author.display_name | Elena Nikiphorou |
| authorships[2].countries | CN |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I200296433, https://openalex.org/I2801228662 |
| authorships[2].affiliations[0].raw_affiliation_string | Peking Union Medical College Hospital (PUMCH), Rheumatology, Beijing, China |
| authorships[2].institutions[0].id | https://openalex.org/I200296433 |
| authorships[2].institutions[0].ror | https://ror.org/02drdmm93 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I200296433 |
| authorships[2].institutions[0].country_code | CN |
| authorships[2].institutions[0].display_name | Chinese Academy of Medical Sciences & Peking Union Medical College |
| authorships[2].institutions[1].id | https://openalex.org/I2801228662 |
| authorships[2].institutions[1].ror | https://ror.org/04jztag35 |
| authorships[2].institutions[1].type | healthcare |
| authorships[2].institutions[1].lineage | https://openalex.org/I2801228662 |
| authorships[2].institutions[1].country_code | CN |
| authorships[2].institutions[1].display_name | Peking Union Medical College Hospital |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | E. Nikiphorou |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Peking Union Medical College Hospital (PUMCH), Rheumatology, Beijing, China |
| authorships[3].author.id | https://openalex.org/A5086543859 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-4875-5395 |
| authorships[3].author.display_name | Ioannis Parodis |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | I. Parodis |
| authorships[3].is_corresponding | False |
| authorships[4].author.id | https://openalex.org/A5109005001 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-3712-5304 |
| authorships[4].author.display_name | N. Ravichandran |
| authorships[4].countries | IN |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I161370692 |
| authorships[4].affiliations[0].raw_affiliation_string | Sanjay Gandhi Postgraduate Institute of Medical Sciences, Department of Clinical Immunology and Rheumatology, Lucknow, India |
| authorships[4].institutions[0].id | https://openalex.org/I161370692 |
| authorships[4].institutions[0].ror | https://ror.org/01rsgrz10 |
| authorships[4].institutions[0].type | facility |
| authorships[4].institutions[0].lineage | https://openalex.org/I161370692 |
| authorships[4].institutions[0].country_code | IN |
| authorships[4].institutions[0].display_name | Sanjay Gandhi Post Graduate Institute of Medical Sciences |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | N. Ravichandran |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Sanjay Gandhi Postgraduate Institute of Medical Sciences, Department of Clinical Immunology and Rheumatology, Lucknow, India |
| authorships[5].author.id | https://openalex.org/A5070801160 |
| authorships[5].author.orcid | https://orcid.org/0000-0001-8528-4361 |
| authorships[5].author.display_name | Jessica Day |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | J. Day |
| authorships[5].is_corresponding | False |
| authorships[6].author.id | https://openalex.org/A5101927945 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-3941-5284 |
| authorships[6].author.display_name | Mohit Joshi |
| authorships[6].countries | IN |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I201202376 |
| authorships[6].affiliations[0].raw_affiliation_string | Byramjee Jeejeebhoy Government Medical College and Sassoon General Hospitals,., Pune, India |
| authorships[6].institutions[0].id | https://openalex.org/I201202376 |
| authorships[6].institutions[0].ror | https://ror.org/00bchtj94 |
| authorships[6].institutions[0].type | education |
| authorships[6].institutions[0].lineage | https://openalex.org/I201202376 |
| authorships[6].institutions[0].country_code | IN |
| authorships[6].institutions[0].display_name | B. J. Medical College & Sassoon Hospital |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | M. Joshi |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Byramjee Jeejeebhoy Government Medical College and Sassoon General Hospitals,., Pune, India |
| authorships[7].author.id | https://openalex.org/A5036523662 |
| authorships[7].author.orcid | https://orcid.org/0000-0001-6745-9770 |
| authorships[7].author.display_name | Sreoshy Saha |
| authorships[7].countries | BD |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I75447333 |
| authorships[7].affiliations[0].raw_affiliation_string | Mymensingh Medical College,., Mymensingh, Bangladesh |
| authorships[7].institutions[0].id | https://openalex.org/I75447333 |
| authorships[7].institutions[0].ror | https://ror.org/000kb2a90 |
| authorships[7].institutions[0].type | healthcare |
| authorships[7].institutions[0].lineage | https://openalex.org/I75447333 |
| authorships[7].institutions[0].country_code | BD |
| authorships[7].institutions[0].display_name | Mymensingh Medical College Hospital |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | S. Saha |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Mymensingh Medical College,., Mymensingh, Bangladesh |
| authorships[8].author.id | https://openalex.org/A5090292029 |
| authorships[8].author.orcid | https://orcid.org/0000-0003-2729-737X |
| authorships[8].author.display_name | Kshitij Jagtap |
| authorships[8].countries | IN |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I193353881 |
| authorships[8].affiliations[0].raw_affiliation_string | Seth Gordhandhas Sunderdas Medical College and King Edwards Memorial Hospital,., Mumbai, Maharashtra, India |
| authorships[8].institutions[0].id | https://openalex.org/I193353881 |
| authorships[8].institutions[0].ror | https://ror.org/03vcw1x21 |
| authorships[8].institutions[0].type | education |
| authorships[8].institutions[0].lineage | https://openalex.org/I193353881 |
| authorships[8].institutions[0].country_code | IN |
| authorships[8].institutions[0].display_name | King Edward Memorial Hospital and Seth G.S. Medical College |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | K. Jagtap |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Seth Gordhandhas Sunderdas Medical College and King Edwards Memorial Hospital,., Mumbai, Maharashtra, India |
| authorships[9].author.id | https://openalex.org/A5041006807 |
| authorships[9].author.orcid | https://orcid.org/0000-0002-8952-5967 |
| authorships[9].author.display_name | Wanruchada Katchamart |
| authorships[9].countries | TH |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I1332387789, https://openalex.org/I25399158 |
| authorships[9].affiliations[0].raw_affiliation_string | Faculty of Medicine Siriraj Hospital, Mahidol University, Division of Rheumatology, Department of Medicine, Bangkok, Thailand |
| authorships[9].institutions[0].id | https://openalex.org/I25399158 |
| authorships[9].institutions[0].ror | https://ror.org/01znkr924 |
| authorships[9].institutions[0].type | education |
| authorships[9].institutions[0].lineage | https://openalex.org/I25399158 |
| authorships[9].institutions[0].country_code | TH |
| authorships[9].institutions[0].display_name | Mahidol University |
| authorships[9].institutions[1].id | https://openalex.org/I1332387789 |
| authorships[9].institutions[1].ror | https://ror.org/0331zs648 |
| authorships[9].institutions[1].type | healthcare |
| authorships[9].institutions[1].lineage | https://openalex.org/I1332387789 |
| authorships[9].institutions[1].country_code | TH |
| authorships[9].institutions[1].display_name | Siriraj Hospital |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | W. Katchamart |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Faculty of Medicine Siriraj Hospital, Mahidol University, Division of Rheumatology, Department of Medicine, Bangkok, Thailand |
| authorships[10].author.id | https://openalex.org/A5017906741 |
| authorships[10].author.orcid | |
| authorships[10].author.display_name | Phonpen Akawatcharangura Goo |
| authorships[10].affiliations[0].raw_affiliation_string | Queen Savang Vadhana Memorial Hospital, Department of Medicine, Chonburi, Thailand |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | P. A. Goo |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Queen Savang Vadhana Memorial Hospital, Department of Medicine, Chonburi, Thailand |
| authorships[11].author.id | https://openalex.org/A5067499670 |
| authorships[11].author.orcid | https://orcid.org/0000-0002-2223-0494 |
| authorships[11].author.display_name | Bijay Vaidya |
| authorships[11].affiliations[0].raw_affiliation_string | National Center for Rheumatic Diseases (NCRD),., Ratopul, Kathmandu, Nepal |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | B. Vaidya |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | National Center for Rheumatic Diseases (NCRD),., Ratopul, Kathmandu, Nepal |
| authorships[12].author.id | https://openalex.org/A5026162378 |
| authorships[12].author.orcid | https://orcid.org/0000-0002-0593-1272 |
| authorships[12].author.display_name | Tsvetelina Velikova |
| authorships[12].countries | BG |
| authorships[12].affiliations[0].institution_ids | https://openalex.org/I58918642 |
| authorships[12].affiliations[0].raw_affiliation_string | Sofia University St. Kliment Ohridski, Medical Faculty, Sofia, Bulgaria |
| authorships[12].institutions[0].id | https://openalex.org/I58918642 |
| authorships[12].institutions[0].ror | https://ror.org/02jv3k292 |
| authorships[12].institutions[0].type | education |
| authorships[12].institutions[0].lineage | https://openalex.org/I58918642 |
| authorships[12].institutions[0].country_code | BG |
| authorships[12].institutions[0].display_name | Sofia University "St. Kliment Ohridski" |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | T. Velikova |
| authorships[12].is_corresponding | False |
| authorships[12].raw_affiliation_strings | Sofia University St. Kliment Ohridski, Medical Faculty, Sofia, Bulgaria |
| authorships[13].author.id | https://openalex.org/A5051263845 |
| authorships[13].author.orcid | https://orcid.org/0000-0002-1630-6026 |
| authorships[13].author.display_name | Parikshit Sen |
| authorships[13].countries | IN |
| authorships[13].affiliations[0].institution_ids | https://openalex.org/I39190216 |
| authorships[13].affiliations[0].raw_affiliation_string | Maulana Azad Medical College,., New Delhi, India |
| authorships[13].institutions[0].id | https://openalex.org/I39190216 |
| authorships[13].institutions[0].ror | https://ror.org/03dwx1z96 |
| authorships[13].institutions[0].type | education |
| authorships[13].institutions[0].lineage | https://openalex.org/I110166357, https://openalex.org/I39190216 |
| authorships[13].institutions[0].country_code | IN |
| authorships[13].institutions[0].display_name | Maulana Azad Medical College |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | P. Sen |
| authorships[13].is_corresponding | False |
| authorships[13].raw_affiliation_strings | Maulana Azad Medical College,., New Delhi, India |
| authorships[14].author.id | https://openalex.org/A5110986739 |
| authorships[14].author.orcid | https://orcid.org/0000-0002-3682-4517 |
| authorships[14].author.display_name | Samuel Katsuyuki Shinjo |
| authorships[14].countries | BR |
| authorships[14].affiliations[0].institution_ids | https://openalex.org/I17974374 |
| authorships[14].affiliations[0].raw_affiliation_string | Universidade de Sao Paulo, Division of Rheumatology, Faculdade de Medicina FMUSP, Sao Paulo, Brazil |
| authorships[14].institutions[0].id | https://openalex.org/I17974374 |
| authorships[14].institutions[0].ror | https://ror.org/036rp1748 |
| authorships[14].institutions[0].type | education |
| authorships[14].institutions[0].lineage | https://openalex.org/I17974374 |
| authorships[14].institutions[0].country_code | BR |
| authorships[14].institutions[0].display_name | Universidade de São Paulo |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | S. Katsuyuki Shinjo |
| authorships[14].is_corresponding | False |
| authorships[14].raw_affiliation_strings | Universidade de Sao Paulo, Division of Rheumatology, Faculdade de Medicina FMUSP, Sao Paulo, Brazil |
| authorships[15].author.id | https://openalex.org/A5015636374 |
| authorships[15].author.orcid | https://orcid.org/0000-0002-4508-1233 |
| authorships[15].author.display_name | Vikas Agarwal |
| authorships[15].affiliations[0].raw_affiliation_string | Mahatma Gandhi Mission Medical College,., Navi Mumbai, Maharashtra, India |
| authorships[15].author_position | middle |
| authorships[15].raw_author_name | V. Agarwal |
| authorships[15].is_corresponding | False |
| authorships[15].raw_affiliation_strings | Mahatma Gandhi Mission Medical College,., Navi Mumbai, Maharashtra, India |
| authorships[16].author.id | https://openalex.org/A5044267541 |
| authorships[16].author.orcid | https://orcid.org/0000-0002-9158-7243 |
| authorships[16].author.display_name | Ai Lyn Tan |
| authorships[16].countries | AR |
| authorships[16].affiliations[0].institution_ids | https://openalex.org/I4210113468 |
| authorships[16].affiliations[0].raw_affiliation_string | Hospital Provincial de Rosario -Santa Fe, Reumatology, Rosario, Argentina; |
| authorships[16].institutions[0].id | https://openalex.org/I4210113468 |
| authorships[16].institutions[0].ror | https://ror.org/0241a4222 |
| authorships[16].institutions[0].type | healthcare |
| authorships[16].institutions[0].lineage | https://openalex.org/I4210113468 |
| authorships[16].institutions[0].country_code | AR |
| authorships[16].institutions[0].display_name | Hospital Provincial de Rosario |
| authorships[16].author_position | middle |
| authorships[16].raw_author_name | A. L. Tan |
| authorships[16].is_corresponding | False |
| authorships[16].raw_affiliation_strings | Hospital Provincial de Rosario -Santa Fe, Reumatology, Rosario, Argentina; |
| authorships[17].author.id | https://openalex.org/A5048798790 |
| authorships[17].author.orcid | https://orcid.org/0000-0002-4479-7678 |
| authorships[17].author.display_name | Nelly Ziadé |
| authorships[17].affiliations[0].raw_affiliation_string | Hospital San Martín, Paraná, Entre Ríos, Reumatology, Parana, Argentina; |
| authorships[17].author_position | middle |
| authorships[17].raw_author_name | N. Ziade |
| authorships[17].is_corresponding | False |
| authorships[17].raw_affiliation_strings | Hospital San Martín, Paraná, Entre Ríos, Reumatology, Parana, Argentina; |
| authorships[18].author.id | https://openalex.org/A5037747961 |
| authorships[18].author.orcid | https://orcid.org/0000-0002-0943-8768 |
| authorships[18].author.display_name | Marcin Milchert |
| authorships[18].countries | PL |
| authorships[18].affiliations[0].institution_ids | https://openalex.org/I79833322 |
| authorships[18].affiliations[0].raw_affiliation_string | Pomeranian Medical University in Szczecin, Department of Internal Medicine, Rheumatology, Diabetology, Geriatrics and Clinical Immunology, Szczecin, Poland |
| authorships[18].institutions[0].id | https://openalex.org/I79833322 |
| authorships[18].institutions[0].ror | https://ror.org/01v1rak05 |
| authorships[18].institutions[0].type | education |
| authorships[18].institutions[0].lineage | https://openalex.org/I79833322 |
| authorships[18].institutions[0].country_code | PL |
| authorships[18].institutions[0].display_name | Pomeranian Medical University |
| authorships[18].author_position | middle |
| authorships[18].raw_author_name | M. Milchert |
| authorships[18].is_corresponding | False |
| authorships[18].raw_affiliation_strings | Pomeranian Medical University in Szczecin, Department of Internal Medicine, Rheumatology, Diabetology, Geriatrics and Clinical Immunology, Szczecin, Poland |
| authorships[19].author.id | https://openalex.org/A5050906412 |
| authorships[19].author.orcid | |
| authorships[19].author.display_name | A. E. Gracia-Ramos |
| authorships[19].countries | MX |
| authorships[19].affiliations[0].institution_ids | https://openalex.org/I164915025, https://openalex.org/I4210088617 |
| authorships[19].affiliations[0].raw_affiliation_string | National Medical Center "La Raza", Instituto Mexicano del Seguro Social, Department of Internal Medicine, Mexico City, Mexico |
| authorships[19].institutions[0].id | https://openalex.org/I4210088617 |
| authorships[19].institutions[0].ror | https://ror.org/004vn8r55 |
| authorships[19].institutions[0].type | healthcare |
| authorships[19].institutions[0].lineage | https://openalex.org/I164915025, https://openalex.org/I4210088617 |
| authorships[19].institutions[0].country_code | MX |
| authorships[19].institutions[0].display_name | Centro Médico Nacional La Raza |
| authorships[19].institutions[1].id | https://openalex.org/I164915025 |
| authorships[19].institutions[1].ror | https://ror.org/03xddgg98 |
| authorships[19].institutions[1].type | government |
| authorships[19].institutions[1].lineage | https://openalex.org/I164915025 |
| authorships[19].institutions[1].country_code | MX |
| authorships[19].institutions[1].display_name | Mexican Social Security Institute |
| authorships[19].author_position | middle |
| authorships[19].raw_author_name | A. E. Gracia-Ramos |
| authorships[19].is_corresponding | False |
| authorships[19].raw_affiliation_strings | National Medical Center "La Raza", Instituto Mexicano del Seguro Social, Department of Internal Medicine, Mexico City, Mexico |
| authorships[20].author.id | https://openalex.org/A5104126489 |
| authorships[20].author.orcid | |
| authorships[20].author.display_name | C. Vinicio Caballero |
| authorships[20].countries | CO |
| authorships[20].affiliations[0].institution_ids | https://openalex.org/I142879360 |
| authorships[20].affiliations[0].raw_affiliation_string | Hospital Universidad del Norte, Department of Medicine, Barranquilla, Atlantico, Colombia |
| authorships[20].institutions[0].id | https://openalex.org/I142879360 |
| authorships[20].institutions[0].ror | https://ror.org/031e6xm45 |
| authorships[20].institutions[0].type | education |
| authorships[20].institutions[0].lineage | https://openalex.org/I142879360 |
| authorships[20].institutions[0].country_code | CO |
| authorships[20].institutions[0].display_name | Universidad del Norte |
| authorships[20].author_position | middle |
| authorships[20].raw_author_name | C. Vinicio Caballero |
| authorships[20].is_corresponding | False |
| authorships[20].raw_affiliation_strings | Hospital Universidad del Norte, Department of Medicine, Barranquilla, Atlantico, Colombia |
| authorships[21].author.id | https://openalex.org/A5065779609 |
| authorships[21].author.orcid | https://orcid.org/0000-0001-6492-1288 |
| authorships[21].author.display_name | Hector Chinoy |
| authorships[21].author_position | middle |
| authorships[21].raw_author_name | H. Chinoy |
| authorships[21].is_corresponding | False |
| authorships[22].author.id | https://openalex.org/A5015636374 |
| authorships[22].author.orcid | https://orcid.org/0000-0002-4508-1233 |
| authorships[22].author.display_name | Vikas Agarwal |
| authorships[22].countries | IN |
| authorships[22].affiliations[0].institution_ids | https://openalex.org/I161370692 |
| authorships[22].affiliations[0].raw_affiliation_string | Sanjay Gandhi Postgraduate Institute of Medical Sciences, Department of Clinical Immunology and Rheumatology, Lucknow, India |
| authorships[22].institutions[0].id | https://openalex.org/I161370692 |
| authorships[22].institutions[0].ror | https://ror.org/01rsgrz10 |
| authorships[22].institutions[0].type | facility |
| authorships[22].institutions[0].lineage | https://openalex.org/I161370692 |
| authorships[22].institutions[0].country_code | IN |
| authorships[22].institutions[0].display_name | Sanjay Gandhi Post Graduate Institute of Medical Sciences |
| authorships[22].author_position | middle |
| authorships[22].raw_author_name | V. Agarwal |
| authorships[22].is_corresponding | False |
| authorships[22].raw_affiliation_strings | Sanjay Gandhi Postgraduate Institute of Medical Sciences, Department of Clinical Immunology and Rheumatology, Lucknow, India |
| authorships[23].author.id | https://openalex.org/A5021312163 |
| authorships[23].author.orcid | https://orcid.org/0000-0001-7531-8038 |
| authorships[23].author.display_name | Rohit Aggarwal |
| authorships[23].countries | US |
| authorships[23].affiliations[0].institution_ids | https://openalex.org/I170201317 |
| authorships[23].affiliations[0].raw_affiliation_string | University of Pittsburgh School of Medicine, Division of Rheumatology and Clinical Immunology, Pennsylvania, United States of America |
| authorships[23].institutions[0].id | https://openalex.org/I170201317 |
| authorships[23].institutions[0].ror | https://ror.org/01an3r305 |
| authorships[23].institutions[0].type | education |
| authorships[23].institutions[0].lineage | https://openalex.org/I170201317 |
| authorships[23].institutions[0].country_code | US |
| authorships[23].institutions[0].display_name | University of Pittsburgh |
| authorships[23].author_position | middle |
| authorships[23].raw_author_name | R. Aggarwal |
| authorships[23].is_corresponding | False |
| authorships[23].raw_affiliation_strings | University of Pittsburgh School of Medicine, Division of Rheumatology and Clinical Immunology, Pennsylvania, United States of America |
| authorships[24].author.id | https://openalex.org/A5004147624 |
| authorships[24].author.orcid | |
| authorships[24].author.display_name | Latika Gupta |
| authorships[24].author_position | middle |
| authorships[24].raw_author_name | L. Gupta |
| authorships[24].is_corresponding | False |
| authorships[25].author.id | https://openalex.org/A5085462671 |
| authorships[25].author.orcid | https://orcid.org/0000-0002-8742-8311 |
| authorships[25].author.display_name | Chris Wincup |
| authorships[25].author_position | last |
| authorships[25].raw_author_name | C. Wincup |
| authorships[25].is_corresponding | False |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://ard.bmj.com/content/annrheumdis/82/Suppl_1/1110.2.full.pdf |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | POS1506 IDENTIFYING DETERMINANTS OF FAVOURABLE AND POOR PHYSICAL FUNCTION IN SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS FROM AN INTERNATIONAL COLLABORATIVE STUDY |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10308 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9769999980926514 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2745 |
| primary_topic.subfield.display_name | Rheumatology |
| primary_topic.display_name | Systemic Lupus Erythematosus Research |
| related_works | https://openalex.org/W2748952813, https://openalex.org/W3031052312, https://openalex.org/W4389568370, https://openalex.org/W3032375762, https://openalex.org/W1995515455, https://openalex.org/W2080531066, https://openalex.org/W3108674512, https://openalex.org/W1506200166, https://openalex.org/W1489783725, https://openalex.org/W2148612803 |
| cited_by_count | 0 |
| locations_count | 1 |
| best_oa_location.id | doi:10.1136/annrheumdis-2023-eular.3754 |
| best_oa_location.is_oa | True |
| best_oa_location.source | |
| best_oa_location.license | |
| best_oa_location.pdf_url | https://ard.bmj.com/content/annrheumdis/82/Suppl_1/1110.2.full.pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | proceedings-article |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Scientific Abstracts |
| best_oa_location.landing_page_url | https://doi.org/10.1136/annrheumdis-2023-eular.3754 |
| primary_location.id | doi:10.1136/annrheumdis-2023-eular.3754 |
| primary_location.is_oa | True |
| primary_location.source | |
| primary_location.license | |
| primary_location.pdf_url | https://ard.bmj.com/content/annrheumdis/82/Suppl_1/1110.2.full.pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | proceedings-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Scientific Abstracts |
| primary_location.landing_page_url | https://doi.org/10.1136/annrheumdis-2023-eular.3754 |
| publication_date | 2023-05-30 |
| publication_year | 2023 |
| referenced_works_count | 0 |
| abstract_inverted_index.2 | 75 |
| abstract_inverted_index.a | 77, 251, 268, 385 |
| abstract_inverted_index.1. | 191 |
| abstract_inverted_index.Ai | 584 |
| abstract_inverted_index.As | 365 |
| abstract_inverted_index.CI | 204, 214, 222, 234, 258, 281, 291, 306, 317 |
| abstract_inverted_index.F. | 514 |
| abstract_inverted_index.To | 54 |
| abstract_inverted_index.as | 164, 384 |
| abstract_inverted_index.by | 138, 778 |
| abstract_inverted_index.in | 7, 27, 64, 93, 154, 183, 189, 396, 421, 447, 465, 794 |
| abstract_inverted_index.no | 42 |
| abstract_inverted_index.of | 34, 80, 179, 357, 369, 405, 418, 428, 799, 806, 816 |
| abstract_inverted_index.or | 133, 242, 814 |
| abstract_inverted_index.to | 51, 60, 90, 127, 131, 166, 206, 216, 224, 236, 246, 260, 267, 283, 293, 298, 308, 319, 342, 388, 414, 656, 688, 721 |
| abstract_inverted_index.vs | 172 |
| abstract_inverted_index.42, | 169 |
| abstract_inverted_index.49, | 174 |
| abstract_inverted_index.95% | 203, 213, 221, 233, 257, 280, 290, 305, 316 |
| abstract_inverted_index.979 | 146 |
| abstract_inverted_index.ANI | 857 |
| abstract_inverted_index.CSL | 532, 830 |
| abstract_inverted_index.Day | 523 |
| abstract_inverted_index.EMD | 834, 875 |
| abstract_inverted_index.Eli | 643, 675, 708, 758, 771 |
| abstract_inverted_index.GPH | 313 |
| abstract_inverted_index.HCs | 151, 167 |
| abstract_inverted_index.Has | 443, 461, 492, 527, 563, 589, 608, 629, 661, 694, 742, 752, 766 |
| abstract_inverted_index.IQR | 170, 175 |
| abstract_inverted_index.Key | 340 |
| abstract_inverted_index.Lyn | 585 |
| abstract_inverted_index.SLE | 65, 68, 147, 158, 186, 331 |
| abstract_inverted_index.Tan | 586 |
| abstract_inverted_index.The | 791 |
| abstract_inverted_index.UCB | 747 |
| abstract_inverted_index.VAS | 288 |
| abstract_inverted_index.Was | 775 |
| abstract_inverted_index.Yan | 431 |
| abstract_inverted_index.age | 201 |
| abstract_inverted_index.and | 20, 41, 115, 149, 209, 227, 286, 311, 349, 353, 371, 457, 475, 485, 505, 513, 569, 595, 604, 614, 623, 636, 650, 668, 682, 701, 715, 748, 773, 802 |
| abstract_inverted_index.are | 25, 38, 187, 654, 686, 719, 797 |
| abstract_inverted_index.but | 239, 263 |
| abstract_inverted_index.can | 5 |
| abstract_inverted_index.for | 450, 468, 592, 597, 611, 616, 782, 811 |
| abstract_inverted_index.had | 159 |
| abstract_inverted_index.its | 394 |
| abstract_inverted_index.key | 32, 56 |
| abstract_inverted_index.may | 360 |
| abstract_inverted_index.not | 240, 264, 803 |
| abstract_inverted_index.of: | 460, 607, 660, 751, 825, 827 |
| abstract_inverted_index.the | 28, 31, 73, 97, 415, 779, 800, 807 |
| abstract_inverted_index.use | 211, 303, 380, 395, 404 |
| abstract_inverted_index.was | 125, 381, 407 |
| abstract_inverted_index.(HC) | 87 |
| abstract_inverted_index.3358 | 150 |
| abstract_inverted_index.AG., | 517 |
| abstract_inverted_index.Elli | 503 |
| abstract_inverted_index.From | 250 |
| abstract_inverted_index.Goo: | 552 |
| abstract_inverted_index.HCs. | 339 |
| abstract_inverted_index.ILD. | 350 |
| abstract_inverted_index.Lee: | 432 |
| abstract_inverted_index.NHS, | 808 |
| abstract_inverted_index.NIL. | 424, 426 |
| abstract_inverted_index.None | 433, 437, 520, 536, 540, 544, 548, 553, 557, 573, 578, 582, 726, 731, 736, 820, 883, 887 |
| abstract_inverted_index.Pain | 274 |
| abstract_inverted_index.Q32, | 836, 874 |
| abstract_inverted_index.SLE. | 422 |
| abstract_inverted_index.Sen: | 572 |
| abstract_inverted_index.Sook | 430 |
| abstract_inverted_index.UCB. | 774 |
| abstract_inverted_index.also | 244, 296, 382, 776 |
| abstract_inverted_index.been | 49 |
| abstract_inverted_index.drug | 420 |
| abstract_inverted_index.fees | 745, 755 |
| abstract_inverted_index.for, | 352 |
| abstract_inverted_index.from | 72, 483, 498, 531, 567, 639, 671, 704, 746, 756, 770 |
| abstract_inverted_index.have | 48 |
| abstract_inverted_index.lung | 229 |
| abstract_inverted_index.more | 81 |
| abstract_inverted_index.none | 653, 685, 718 |
| abstract_inverted_index.pain | 370 |
| abstract_inverted_index.poor | 134, 196, 343, 376 |
| abstract_inverted_index.show | 332 |
| abstract_inverted_index.than | 82 |
| abstract_inverted_index.that | 24, 58, 399 |
| abstract_inverted_index.this | 47, 419, 657, 689, 722, 795 |
| abstract_inverted_index.used | 126 |
| abstract_inverted_index.were | 70, 88, 120, 152, 322, 373 |
| abstract_inverted_index.with | 157, 185, 195, 324, 330, 338, 375, 409 |
| abstract_inverted_index.(BI), | 844, 880 |
| abstract_inverted_index.(GMH) | 119 |
| abstract_inverted_index.(GPH) | 114 |
| abstract_inverted_index.(ILD) | 231 |
| abstract_inverted_index.(SLE) | 4 |
| abstract_inverted_index.(VAS) | 278 |
| abstract_inverted_index.0.190 | 307 |
| abstract_inverted_index.2.079 | 318 |
| abstract_inverted_index.36-47 | 171 |
| abstract_inverted_index.Astra | 761 |
| abstract_inverted_index.Binit | 555 |
| abstract_inverted_index.COPD, | 243 |
| abstract_inverted_index.COVAD | 74 |
| abstract_inverted_index.Carlo | 733 |
| abstract_inverted_index.Chris | 885 |
| abstract_inverted_index.Edgar | 729 |
| abstract_inverted_index.Elena | 439 |
| abstract_inverted_index.Holds | 480 |
| abstract_inverted_index.Lilly | 504, 772 |
| abstract_inverted_index.Nelly | 625 |
| abstract_inverted_index.PF-10 | 300 |
| abstract_inverted_index.Roche | 516 |
| abstract_inverted_index.Rohit | 822 |
| abstract_inverted_index.Saha: | 539 |
| abstract_inverted_index.Table | 190 |
| abstract_inverted_index.Teva, | 855 |
| abstract_inverted_index.UCB., | 605, 624 |
| abstract_inverted_index.Vikas | 818 |
| abstract_inverted_index.Ziade | 626 |
| abstract_inverted_index.board | 634, 666, 699 |
| abstract_inverted_index.could | 392 |
| abstract_inverted_index.daily | 9 |
| abstract_inverted_index.date. | 52 |
| abstract_inverted_index.early | 355 |
| abstract_inverted_index.fees, | 632, 635, 664, 667, 697, 700 |
| abstract_inverted_index.from: | 479, 491, 526, 693, 765, 866, 869 |
| abstract_inverted_index.grant | 768 |
| abstract_inverted_index.limit | 400 |
| abstract_inverted_index.lower | 161, 247, 269, 299 |
| abstract_inverted_index.lupus | 2 |
| abstract_inverted_index.score | 163, 314 |
| abstract_inverted_index.these | 358 |
| abstract_inverted_index.those | 798, 805 |
| abstract_inverted_index.using | 96 |
| abstract_inverted_index.views | 792 |
| abstract_inverted_index.which | 391 |
| abstract_inverted_index.-0.069 | 205 |
| abstract_inverted_index.-1.844 | 215 |
| abstract_inverted_index.-1.853 | 259 |
| abstract_inverted_index.-1.974 | 292 |
| abstract_inverted_index.-3.107 | 282 |
| abstract_inverted_index.-3.481 | 223 |
| abstract_inverted_index.-4.366 | 235 |
| abstract_inverted_index.1.498, | 309 |
| abstract_inverted_index.2.494, | 320 |
| abstract_inverted_index.20,000 | 83 |
| abstract_inverted_index.45-50, | 176 |
| abstract_inverted_index.Amelia | 435 |
| abstract_inverted_index.Amgen, | 499 |
| abstract_inverted_index.Centre | 788 |
| abstract_inverted_index.Chinoy | 739 |
| abstract_inverted_index.Fabre; | 652, 684, 717 |
| abstract_inverted_index.Gilead | 507 |
| abstract_inverted_index.Global | 111, 116 |
| abstract_inverted_index.Gupta: | 882 |
| abstract_inverted_index.Health | 113, 118, 783, 812 |
| abstract_inverted_index.Hector | 738 |
| abstract_inverted_index.Higher | 273 |
| abstract_inverted_index.Joshi: | 535 |
| abstract_inverted_index.Kezar, | 837 |
| abstract_inverted_index.Latika | 881 |
| abstract_inverted_index.Lilly, | 458, 476, 486, 601, 620, 644, 676, 709, 759 |
| abstract_inverted_index.Marcin | 724 |
| abstract_inverted_index.Mental | 117 |
| abstract_inverted_index.Merck, | 849 |
| abstract_inverted_index.Naveen | 518 |
| abstract_inverted_index.Nuvig, | 860 |
| abstract_inverted_index.PF-10a | 143, 162, 248 |
| abstract_inverted_index.PROMIS | 139 |
| abstract_inverted_index.Pfizer | 484, 568 |
| abstract_inverted_index.Pierre | 651, 683, 716 |
| abstract_inverted_index.Roche, | 641, 673, 706 |
| abstract_inverted_index.Samuel | 575 |
| abstract_inverted_index.Scales | 277 |
| abstract_inverted_index.System | 103 |
| abstract_inverted_index.Visual | 275 |
| abstract_inverted_index.active | 16 |
| abstract_inverted_index.adding | 413 |
| abstract_inverted_index.and/or | 496 |
| abstract_inverted_index.asthma | 241 |
| abstract_inverted_index.boards | 449, 467, 594, 613 |
| abstract_inverted_index.common | 26 |
| abstract_inverted_index.confer | 361 |
| abstract_inverted_index.factor | 387 |
| abstract_inverted_index.global | 44, 78 |
| abstract_inverted_index.grants | 482, 638, 670, 703 |
| abstract_inverted_index.health | 22, 253 |
| abstract_inverted_index.higher | 312, 367 |
| abstract_inverted_index.levels | 368 |
| abstract_inverted_index.median | 173 |
| abstract_inverted_index.mental | 21, 252 |
| abstract_inverted_index.poorly | 39 |
| abstract_inverted_index.result | 6 |
| abstract_inverted_index.score. | 249, 272 |
| abstract_inverted_index.status | 182 |
| abstract_inverted_index.(0.844, | 304 |
| abstract_inverted_index.(2.287, | 315 |
| abstract_inverted_index.(median | 168 |
| abstract_inverted_index.-0.012, | 217 |
| abstract_inverted_index.-0.015, | 207 |
| abstract_inverted_index.-0.087, | 261 |
| abstract_inverted_index.-0.243, | 225 |
| abstract_inverted_index.-0.517, | 237 |
| abstract_inverted_index.-0.945, | 294 |
| abstract_inverted_index.-2.671, | 284 |
| abstract_inverted_index.AbbVie, | 456, 474 |
| abstract_inverted_index.Abbvie, | 598, 617, 642, 674, 707 |
| abstract_inverted_index.Abraham | 728 |
| abstract_inverted_index.Argenx, | 841 |
| abstract_inverted_index.Aurinia | 501 |
| abstract_inverted_index.Biogen, | 749, 859 |
| abstract_inverted_index.Bristol | 872 |
| abstract_inverted_index.Capella | 861 |
| abstract_inverted_index.Corbus, | 845 |
| abstract_inverted_index.Fatigue | 287 |
| abstract_inverted_index.Funding | 789 |
| abstract_inverted_index.Gilead, | 454, 472, 599, 618 |
| abstract_inverted_index.Healthy | 85 |
| abstract_inverted_index.Horizon | 853 |
| abstract_inverted_index.Ioannis | 487 |
| abstract_inverted_index.Jagtap: | 543 |
| abstract_inverted_index.Janssen | 510 |
| abstract_inverted_index.Jessica | 522 |
| abstract_inverted_index.Kshitij | 542 |
| abstract_inverted_index.Mrudula | 534 |
| abstract_inverted_index.Outcome | 100 |
| abstract_inverted_index.Parodis | 488 |
| abstract_inverted_index.Patient | 98 |
| abstract_inverted_index.Pfizer, | 452, 470, 603, 622, 640, 672, 705, 838, 871 |
| abstract_inverted_index.Phonpen | 550 |
| abstract_inverted_index.Sanofi, | 453, 471 |
| abstract_inverted_index.Scheme. | 790 |
| abstract_inverted_index.Serono, | 835, 876 |
| abstract_inverted_index.Shinjo: | 577 |
| abstract_inverted_index.Sreoshy | 538 |
| abstract_inverted_index.Vaidya: | 556 |
| abstract_inverted_index.Vinicio | 734 |
| abstract_inverted_index.Wincup: | 886 |
| abstract_inverted_index.Zeneca, | 762 |
| abstract_inverted_index.anxiety | 255 |
| abstract_inverted_index.authors | 801 |
| abstract_inverted_index.bureau: | 442, 562, 588, 628, 741 |
| abstract_inverted_index.chronic | 18 |
| abstract_inverted_index.compare | 91 |
| abstract_inverted_index.damage, | 19 |
| abstract_inverted_index.disease | 109, 230 |
| abstract_inverted_index.drivers | 33 |
| abstract_inverted_index.factors | 57, 130, 193 |
| abstract_inverted_index.fatigue | 372 |
| abstract_inverted_index.funding | 495, 530 |
| abstract_inverted_index.include | 346 |
| abstract_inverted_index.reduced | 35, 334, 389 |
| abstract_inverted_index.related | 655, 687, 720 |
| abstract_inverted_index.score). | 144 |
| abstract_inverted_index.scores. | 301 |
| abstract_inverted_index.speaker | 445, 463, 565, 631, 663, 696 |
| abstract_inverted_index.studies | 45 |
| abstract_inverted_index.support | 478, 490, 525, 692, 764, 769, 865, 868 |
| abstract_inverted_index.through | 12 |
| abstract_inverted_index.various | 13 |
| abstract_inverted_index.(-0.042, | 202 |
| abstract_inverted_index.(-0.928, | 212 |
| abstract_inverted_index.(-0.970, | 256 |
| abstract_inverted_index.(-1.459, | 289 |
| abstract_inverted_index.(-1.862, | 220 |
| abstract_inverted_index.(-2.441, | 232 |
| abstract_inverted_index.(-2.889, | 279 |
| abstract_inverted_index.(PROMIS) | 104 |
| abstract_inverted_index.Agarwal: | 581, 819 |
| abstract_inverted_index.Aggarwal | 823 |
| abstract_inverted_index.Alexion, | 840 |
| abstract_inverted_index.Analogue | 276 |
| abstract_inverted_index.Behring, | 831 |
| abstract_inverted_index.Beigene, | 856 |
| abstract_inverted_index.Briefly, | 192 |
| abstract_inverted_index.Bristol. | 832 |
| abstract_inverted_index.Company, | 506 |
| abstract_inverted_index.Diabetes | 219 |
| abstract_inverted_index.Function | 141 |
| abstract_inverted_index.Health., | 817 |
| abstract_inverted_index.However, | 30 |
| abstract_inverted_index.Janssen, | 600, 619, 649, 681, 714, 846, 877 |
| abstract_inverted_index.Kyverna, | 847 |
| abstract_inverted_index.National | 780, 809 |
| abstract_inverted_index.Novartis | 512 |
| abstract_inverted_index.Patients | 156, 329 |
| abstract_inverted_index.Physical | 112, 140 |
| abstract_inverted_index.Reported | 99 |
| abstract_inverted_index.Research | 784, 787 |
| abstract_inverted_index.Roivant, | 848 |
| abstract_inverted_index.Scipher, | 852 |
| abstract_inverted_index.Speakers | 441, 561, 587, 627, 740 |
| abstract_inverted_index.Systemic | 1 |
| abstract_inverted_index.Velikova | 560 |
| abstract_inverted_index.Vishwesh | 580 |
| abstract_inverted_index.advisory | 448, 466, 593, 612, 633, 665, 698 |
| abstract_inverted_index.analysis | 124 |
| abstract_inverted_index.benefits | 417 |
| abstract_inverted_index.compared | 165, 337 |
| abstract_inverted_index.controls | 86 |
| abstract_inverted_index.diabetes | 348 |
| abstract_inverted_index.disease, | 17 |
| abstract_inverted_index.disease. | 29 |
| abstract_inverted_index.function | 11, 37, 63, 95, 136, 181, 198, 271, 336, 345 |
| abstract_inverted_index.identify | 128 |
| abstract_inverted_index.impaired | 8, 61 |
| abstract_inverted_index.improved | 362 |
| abstract_inverted_index.included | 89, 153, 199 |
| abstract_inverted_index.p=0.002) | 208 |
| abstract_inverted_index.p=0.012) | 310 |
| abstract_inverted_index.p=0.024) | 226 |
| abstract_inverted_index.p=0.031) | 262 |
| abstract_inverted_index.patients | 69, 148, 184 |
| abstract_inverted_index.physical | 10, 36, 62, 94, 135, 180, 197, 270, 326, 335, 344, 377, 401, 411 |
| abstract_inverted_index.received | 444, 462, 493, 528, 564, 590, 609, 630, 662, 695, 743, 753, 767 |
| abstract_inverted_index.register | 79 |
| abstract_inverted_index.research | 481, 494, 529, 637, 669, 702 |
| abstract_inverted_index.speaking | 596, 615, 744 |
| abstract_inverted_index.symptoms | 23 |
| abstract_inverted_index.(measured | 137 |
| abstract_inverted_index.Holloway: | 436 |
| abstract_inverted_index.Ingelheim | 843, 879 |
| abstract_inverted_index.Institute | 810 |
| abstract_inverted_index.Katsuyuki | 576 |
| abstract_inverted_index.Limited., | 533 |
| abstract_inverted_index.Milchert: | 725 |
| abstract_inverted_index.Novartis, | 602, 621, 757 |
| abstract_inverted_index.Parikshit | 571 |
| abstract_inverted_index.Research, | 813 |
| abstract_inverted_index.Sciences, | 508 |
| abstract_inverted_index.Screening | 351 |
| abstract_inverted_index.activity, | 110 |
| abstract_inverted_index.analysis. | 155 |
| abstract_inverted_index.articular | 397 |
| abstract_inverted_index.conducted | 50 |
| abstract_inverted_index.database, | 76 |
| abstract_inverted_index.declared, | 434, 438, 521, 537, 541, 545, 549, 554, 558, 574, 579, 583, 727, 732, 737, 821, 884 |
| abstract_inverted_index.declared. | 888 |
| abstract_inverted_index.expected, | 366 |
| abstract_inverted_index.expressed | 793 |
| abstract_inverted_index.function, | 390, 412 |
| abstract_inverted_index.function. | 327, 364, 378, 402 |
| abstract_inverted_index.globally. | 66 |
| abstract_inverted_index.honoraria | 497, 566, 591, 610 |
| abstract_inverted_index.including | 15 |
| abstract_inverted_index.long-term | 363 |
| abstract_inverted_index.p=0.013), | 238 |
| abstract_inverted_index.p=0.047). | 218 |
| abstract_inverted_index.represent | 393 |
| abstract_inverted_index.shortform | 142 |
| abstract_inverted_index.supported | 777 |
| abstract_inverted_index.treatment | 356 |
| abstract_inverted_index.Actigraph, | 851 |
| abstract_inverted_index.Biomedical | 786 |
| abstract_inverted_index.Boehringer | 647, 679, 712, 842, 878 |
| abstract_inverted_index.Caballero: | 735 |
| abstract_inverted_index.Celltrion, | 451, 469 |
| abstract_inverted_index.Consultant | 459, 606, 659, 750, 824, 826 |
| abstract_inverted_index.Department | 815 |
| abstract_inverted_index.Galapagos, | 455, 473, 850 |
| abstract_inverted_index.Ingelheim, | 648, 680, 713 |
| abstract_inverted_index.Manchester | 785 |
| abstract_inverted_index.NewBridge, | 645, 677, 710 |
| abstract_inverted_index.Nikiphorou | 440 |
| abstract_inverted_index.Orphazyme, | 760 |
| abstract_inverted_index.Tsvetelina | 559 |
| abstract_inverted_index.Wanruchada | 546 |
| abstract_inverted_index.aggressive | 354 |
| abstract_inverted_index.associated | 194, 323, 374, 408 |
| abstract_inverted_index.collected. | 121 |
| abstract_inverted_index.conditions | 359 |
| abstract_inverted_index.consulting | 754 |
| abstract_inverted_index.contribute | 59 |
| abstract_inverted_index.depression | 265 |
| abstract_inverted_index.favourable | 132, 325, 410 |
| abstract_inverted_index.identified | 71, 383 |
| abstract_inverted_index.increasing | 200 |
| abstract_inverted_index.mechanisms | 14 |
| abstract_inverted_index.regression | 123 |
| abstract_inverted_index.summarised | 188 |
| abstract_inverted_index.Bioscience, | 862 |
| abstract_inverted_index.Hoffmann-La | 515 |
| abstract_inverted_index.Information | 102 |
| abstract_inverted_index.Institution | 781 |
| abstract_inverted_index.Katchamart: | 547 |
| abstract_inverted_index.Measurement | 101 |
| abstract_inverted_index.Octapharma, | 829 |
| abstract_inverted_index.contributed | 245, 266, 297 |
| abstract_inverted_index.differences | 92 |
| abstract_inverted_index.investigate | 55 |
| abstract_inverted_index.large-scale | 43 |
| abstract_inverted_index.medication, | 107 |
| abstract_inverted_index.necessarily | 804 |
| abstract_inverted_index.p<0.001) | 285, 295, 321 |
| abstract_inverted_index.publication | 796 |
| abstract_inverted_index.understood, | 40 |
| abstract_inverted_index.AstraZeneca, | 500, 839 |
| abstract_inverted_index.Determinants | 178 |
| abstract_inverted_index.Importantly, | 403 |
| abstract_inverted_index.Methotrexate | 379 |
| abstract_inverted_index.contributing | 129, 386 |
| abstract_inverted_index.contributors | 341 |
| abstract_inverted_index.intercurrent | 347 |
| abstract_inverted_index.interstitial | 228 |
| abstract_inverted_index.manuscript., | 658, 690, 723 |
| abstract_inverted_index.methotrexate | 210 |
| abstract_inverted_index.perspective, | 254 |
| abstract_inverted_index.respondents. | 84 |
| abstract_inverted_index.AstraZeneca., | 570 |
| abstract_inverted_index.Demographics, | 106 |
| abstract_inverted_index.Gracia-Ramos: | 730 |
| abstract_inverted_index.Mallinckrodt, | 828, 870 |
| abstract_inverted_index.Multivariable | 122 |
| abstract_inverted_index.Myers-Squibb, | 833, 873 |
| abstract_inverted_index.Ravichandran: | 519 |
| abstract_inverted_index.Therapeutics, | 854 |
| abstract_inverted_index.erythematosus | 3 |
| abstract_inverted_index.investigating | 46 |
| abstract_inverted_index.p<0.0001). | 177 |
| abstract_inverted_index.significantly | 160, 333 |
| abstract_inverted_index.<h3>Disclosure | 427 |
| abstract_inverted_index.CabalettaBio., | 863 |
| abstract_inverted_index.Grant/research | 477, 489, 524, 691, 763, 864, 867 |
| abstract_inverted_index.Interests</h3> | 429 |
| abstract_inverted_index.comorbidities, | 108 |
| abstract_inverted_index.manifestations | 398 |
| abstract_inverted_index.questionnaire. | 105 |
| abstract_inverted_index.Sanofi-Aventis, | 646, 678, 711 |
| abstract_inverted_index.well-recognised | 416 |
| abstract_inverted_index.<h3>Methods</h3> | 67 |
| abstract_inverted_index.<h3>Results</h3> | 145 |
| abstract_inverted_index.GlaxoSmithKline, | 509 |
| abstract_inverted_index.Pharmaceuticals, | 502, 511, 858 |
| abstract_inverted_index.Akarawatcharangura | 551 |
| abstract_inverted_index.Hydroxychloroquine | 302 |
| abstract_inverted_index.hydroxychloroquine | 406 |
| abstract_inverted_index.<h3>Background</h3> | 0 |
| abstract_inverted_index.<h3>Conclusion</h3> | 328 |
| abstract_inverted_index.<h3>Objectives</h3> | 53 |
| abstract_inverted_index.<h3>REFERENCES:</h3> | 423 |
| abstract_inverted_index.honoraria/participated | 446, 464 |
| abstract_inverted_index.<h3>Acknowledgements:</h3> | 425 |
| cited_by_percentile_year | |
| countries_distinct_count | 12 |
| institutions_distinct_count | 26 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/1 |
| sustainable_development_goals[0].score | 0.7099999785423279 |
| sustainable_development_goals[0].display_name | No poverty |
| citation_normalized_percentile.value | 0.18239533 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |